166 related articles for article (PubMed ID: 9690451)
1. A review of the association between interleukin-10 and human B-cell malignancies.
Khatri VP; Caligiuri MA
Cancer Immunol Immunother; 1998 Jul; 46(5):239-44. PubMed ID: 9690451
[No Abstract] [Full Text] [Related]
2. Expression of the two alternative [a] and [b] transcripts of CCND1 gene in cyclin D1-expressing B-malignancies: relevance for the pathogenesis.
Roué G; Krieger S; Florent M; Roussel M; Duquesne F; Troussard X; Pichereau V; Sola B
Leukemia; 2003 Mar; 17(3):652-5. PubMed ID: 12646964
[No Abstract] [Full Text] [Related]
3. The emerging role of estrogen in B cell malignancies.
Ladikou EE; Kassi E
Leuk Lymphoma; 2017 Mar; 58(3):528-539. PubMed ID: 27557932
[TBL] [Abstract][Full Text] [Related]
4. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
5. VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects.
Härzschel A; Zucchetto A; Gattei V; Hartmann TN
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210016
[TBL] [Abstract][Full Text] [Related]
6. cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.
Domka K; Goral A; Firczuk M
Front Immunol; 2020; 11():1538. PubMed ID: 32793211
[TBL] [Abstract][Full Text] [Related]
7. B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders.
Morse HC; McCarty T; Qi CF; Torrey TA; Naghashfar Z; Chattopadhyay SK; Fredrickson TN; Hartley JW
Adv Immunol; 2003; 81():97-121. PubMed ID: 14711054
[No Abstract] [Full Text] [Related]
8. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.
Nepomuceno RR; Balatoni CE; Natkunam Y; Snow AL; Krams SM; Martinez OM
Cancer Res; 2003 Aug; 63(15):4472-80. PubMed ID: 12907620
[TBL] [Abstract][Full Text] [Related]
9. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract][Full Text] [Related]
10. PU.1 is a tumor suppressor for B cell malignancies.
Okuno Y; Yuki H
Oncotarget; 2012 Dec; 3(12):1495-6. PubMed ID: 23455457
[No Abstract] [Full Text] [Related]
11. [Constitutive activation of B cell antigen receptor-associated tyrosine kinases in B cell leukemia/lymphoma lines].
Ueno H; Odai H
Rinsho Ketsueki; 1998 Feb; 39(2):89-91. PubMed ID: 9545806
[No Abstract] [Full Text] [Related]
12. Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disorders.
Ogasawara T; Yasuyama M; Kawauchi K
Int J Hematol; 2003 May; 77(4):364-70. PubMed ID: 12774925
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.
Bao Y; Cao X
Clin Rev Allergy Immunol; 2016 Jun; 50(3):301-11. PubMed ID: 26066671
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Mouse Models of B Cell Malignancies.
Perez-Chacon G; Vincent-Fabert C; Zapata JM
Front Immunol; 2021; 12():789901. PubMed ID: 34777400
[No Abstract] [Full Text] [Related]
15. Development of Tumor-Targeting IRE-1 Inhibitors for B-cell Cancer Therapy.
Shao A; Xu Q; Spalek WT; Cain CF; Kang CW; Tang CA; Del Valle JR; Hu CA
Mol Cancer Ther; 2020 Dec; 19(12):2432-2444. PubMed ID: 33051362
[TBL] [Abstract][Full Text] [Related]
16. Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy.
Libert D; Yuan CM; Masih KE; Galera P; Salem D; Shalabi H; Yates B; Delbrook C; Shern JF; Fry TJ; Khan J; Stetler-Stevenson M; Shah NN
Leukemia; 2020 Nov; 34(11):3064-3069. PubMed ID: 32103145
[No Abstract] [Full Text] [Related]
17. Bruton tyrosine kinase (BTK) and its role in B-cell malignancy.
Buggy JJ; Elias L
Int Rev Immunol; 2012 Apr; 31(2):119-32. PubMed ID: 22449073
[TBL] [Abstract][Full Text] [Related]
18. The potential role of cytokines in the pathogenesis of Epstein-Barr virus associated post-transplant lymphoproliferative disease.
Randhawa PS; Demetris AJ; Nalesnik MA
Leuk Lymphoma; 1994 Nov; 15(5-6):383-7. PubMed ID: 7873995
[TBL] [Abstract][Full Text] [Related]
19. Role of an immunosuppressive cytokine, interleukin-10, in the development of pyothorax-associated lymphoma.
Kanno H; Naka N; Yasunaga Y; Aozasa K
Leukemia; 1997 Apr; 11 Suppl 3():525-6. PubMed ID: 9209445
[TBL] [Abstract][Full Text] [Related]
20. A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukemia.
dos Santos NR; Ghysdael J
Leukemia; 2006 Jan; 20(1):182-5. PubMed ID: 16281066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
